The Canadian COVID‑19 Funded Research Database

The University of Calgary

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 71 through 80 of 122 results (Download Results)

Show results per page

COVID-19 Variant Supplement – Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses

Houghton, Michael | University of Alberta | Operating Grant | $50,000

CIHR Alberta 2021

COVID-19 Variant Supplement – Targeting programmed ribosomal frameshifting as a therapeutic strategy against 2019-nCoV

Woodside, Michael T | University of Alberta | Operating Grant | $50,000

CIHR Alberta 2021

COVID-19 Variant Supplement – Household Transmission Dynamics and Vial Load among Asymptomatic SARS-CoV-2 Infected Children

Freedman, Stephen B | The University of Calgary | Operating Grant | $49,932

CIHR Alberta 2021

COVID-19 Variant Network – Detection and quantitation of SARS-CoV-2 in wastewater to conduct surveillance on burden of community infection, identify outbreaks and support public health decision-making on control measures for transmission of COVID-19

Pang, Xiaoli L | University of Alberta | Operating Grant | $99,970

CIHR Alberta 2021

Implementation of Pathway for Goals of Care and End of Life Management in L

Goodarzi, Zahra S | The University of Calgary | Operating Grant | $147,875

CIHR Alberta 2020

COVID-19 Variant Supplement – Screening Student Resiliency and Mental Health Indicators During School Re-Entry

Schwartz, Kelly D | The University of Calgary | Operating Grant | $49,063

CIHR Alberta 2021

Rational design and standardization of serology diagnostics using immunoaffinity-targeted proteomics assays

Drabovich, Andrei P | University of Alberta | Operating Grant | $215,500

CIHR Alberta 2020

A Prospective Pan-Canadian Cohort Assessment of SARS-CoV-2 Variant of Concern Disease Severity and Association with Long-Term Symptoms in Children

Freedman, Stephen B | The University of Calgary | Operating Grant | $465,120

CIHR Alberta 2021

Rapid RNA sequencing of coronavirus for public health surveillance and transmission

Croxen, Matthew A | University of Alberta | Operating Grant | $788,040

CIHR Alberta 2020

Targeting programmed ribosomal frameshifting as a therapeutic strategy against 2019-nCoV

Woodside, Michael T | University of Alberta | Operating Grant | $462,406

CIHR Alberta 2020

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

COVID-19 Variant Supplement – Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses

COVID-19 Variant Supplement – Targeting programmed ribosomal frameshifting as a therapeutic strategy against 2019-nCoV

COVID-19 Variant Supplement – Household Transmission Dynamics and Vial Load among Asymptomatic SARS-CoV-2 Infected Children

COVID-19 Variant Network – Detection and quantitation of SARS-CoV-2 in wastewater to conduct surveillance on burden of community infection, identify outbreaks and support public health decision-making on control measures for transmission of COVID-19

Implementation of Pathway for Goals of Care and End of Life Management in L

COVID-19 Variant Supplement – Screening Student Resiliency and Mental Health Indicators During School Re-Entry

Rational design and standardization of serology diagnostics using immunoaffinity-targeted proteomics assays

A Prospective Pan-Canadian Cohort Assessment of SARS-CoV-2 Variant of Concern Disease Severity and Association with Long-Term Symptoms in Children

Rapid RNA sequencing of coronavirus for public health surveillance and transmission

Targeting programmed ribosomal frameshifting as a therapeutic strategy against 2019-nCoV